Elan Corporation

Pharmaceutical company

About Us

Products

Elan Drug Technologies

Research & Development

News

Investor Relations

Careers

Governance

Site Map

About Us	Products	Elan Drug Technologies	Research & Development	News	Investor Relations	Careers	Governance
Executive Management	United States	NanoCrystal® Technology	Alzheimer's Research	2005	Shareholder Information	Benefits	Board of Directors
Corporate Governance	European Union	Oral Controlled Release	Pipeline & Products	2004	Financials	Job Search	Committee Memberships
Facilities		Manufacturing & Scale-up	AD/PD site	2003	Events & Webcasts		Governance Guidelines
		Collaborations		PRIALT® Media Kit	Company Overview		Committee Charters
		Announcements		PRIALT™ EU Media Kit	Corporate Governance		Code of Conduct
		Contact Us			Senior Management		Articles of Association
					Information Request		Corporate Compliance
					Contacts

TYSABRI is a registered trademark of Elan Pharmaceuticals, Inc. in the United States and of Elan Pharma International Ltd. in various countries outside the United States.

PRIALT is a registered trademark of Elan Pharmaceuticals, Inc. 

AZACTAM and MAXIPIME are registered trademarks of Bristol-Myers Squibb Company and licensed exclusively in the U.S.to Elan Pharmaceuticals, Inc.

Copyright © 2001- 2004 Elan Corporation, plc, Dublin, Ireland. All rights reserved. | Privacy Policy | Terms of use